Aims: To investigate whether counting cells containing immunoglobulin (Ig) 
Differentiation of chronic inflammatory bowel disease (CIBD) in Crohn's disease and ulcerative colitis is important from the clinical and surgical point of view.'2 Although the biopsy features of acute self limiting colitis and CIBD have been well described and criteria for distinguishing between them have been validated statistically,3 studies on the Crohn's disease features that distinguish from ulcerative colitis are scarce. 7 In a previous study8 we determined which histological features in colonic biopsy specimens are reproducible. Moreover, using multivariate discriminant analysis, we selected the combination of excess histiocytes in the lamina propria, the aspect of the mucosal surface, and the presence of granulomas as the most useful features for making a reliable distinction between Crohn's disease and ulcerative colitis. With these features 70% of those with Crohn's disease and 75% of those patients with ulcerative colitis were correctly classified with a high a posteriori probability (>0 85). The false positive rate was 10% for Crohn's disease and 4%/o for ulcerative colitis.8
Several studies have shown differences between the number of immunoglobulin (Ig) containing cells in the lamina propria of colonic and rectal biopsy specimens of patients with Crohn's disease and those with ulcerative colitis.1"5 IgM containing cells tend to be increased in colonic biopsy specimens from patients with Crohn's disease compared with those with ulcerative colitis,>" and this finding has subsequently been confirmed in surgical colonic resection specimens. '5 16 These studies, however, are concerned only with differences in Ig subclass bearing cells in groups of patients with ulcerative colitis or Crohn's disease. The predictive value of counts of Ig containing cells in undiagnosed patients to distinguish Crohn's disease from ulcerative colitis has not been elucidated in these studies. To our knowledge, only Jenkins et a156 investigated whether Ig cell counting in addition to histological features was useful to differentiate between Crohn's disease and ulcerative colitis in individual patients, but their results were controversial. The aim of the present study was to determine whether counting Ig containing cells in colonic mucosal biopsy specimens of clinically well defined patients in addition to conventional histological evaluation8 could improve the differentiation of individual patients with Crohn's disease from those with ulcerative colitis.
Methods
The colonic and rectal biopsy specimens of 40 patients with CIBD, comprising 20 with Crohn's disease (seven men, 13 women; mean age 31U7 years, range 21-62 years) and 20 with ulcerative colitis (13 men, seven women; mean age 37 years, range 15-70 years) were used in this immunohistochemical study. All these clinically defined patients had a colonoscopy or sigmoidoscopy and multiple biopsy specimens were taken, usually from the descending colon, sigmoid, and rectum, and if possible from transverse and ascending colon (table 1). For further clinical information the reader is referred to our previous study. 8 At least three specimens were taken from each site; therefore, usually nine biopsy specimens per patient were studied, and from some, nine to 15 1) . The selection of the mucosal field was made on the subjective estimation that the field contained the largest number of Ig subclass cells in that biopsy specimen. The Ig subclass containing cells were counted in at least one field of each of the three biopsy specimens from each site. At each biopsy location the mean percentage of IgM, IgA, and IgG containing cells was calculated. The cell counts were expressed as percentages of the total number of Ig subclass containing cells per mm2 of lamina propria. To stabilise the variation in the running mean of counts of Ig subclass containing cells per biopsy location at least 600 Ig containing cells had to be counted, as described in our previous study.'9 Therefore, ifafter counting ofthe three mucosal fields the total number of Ig containing cell counts was less than 600, consecutive fields in each biopsy specimen were selected and Ig containing cells were counted until a total number of 600 Ig containing cells were counted per biopsy location. The reproducibility of this counting method is sufficient to detect differences in the mean counts of IgA and IgG containing cells of more than 10%, whereas the differences in the mean counts of IgM must exceed 5%. '9 According to this protocol several parameters were recorded: 1 At each biopsy location, the mean percentage of IgM, IgA, and IgG containing cells in the three biopsy specimens (expressed as percentages of the total number of cells per mm2 of lamina propria) was defined as: If only Ig subclass containing cell counting was used, IgMmax was selected as the strongest feature to discriminate between Crohn's disease and ulcerative colitis. The addition of other Ig subclass containing cell counts did not result in a better classification. Jackknifed classification of the analysis was performed to evaluate the discriminant function. As in our previous study8 values of 0-15 and 0 85 were used as cutoff points for the a posteriori probabilities. A patient was predicted to have ulcerative colitis when the ulcerative colitis a posteriori probability was larger than 0-85, and was diagnosed as having Crohn's disease when the a posteriori probability is smaller than 0 15. Indeterminate CIBD was classified when the a posteriori probability lay between or was equal to 0-15 and 0-85.
Using IgMmax as the discriminant feature eight of 20 (35 %) patients with Crohn's disease and seven of 19 (37%) of those with ulcerative colitis were correctly classified ( fig 2) According to the jackknifed classification, the combination of these three criteria permitted an accurate diagnosis with a high a posteriori probability (>0-85) in 18 of 20 (90%) patients with Crohn's disease and 16 of 19 (84%) with ulcerative colitis (fig 3 and table 3 
